Thomas Deering, MD
Clinical Cardiac Electrophysiology · Atlanta, GANPI 1932104239
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $213,735 of the $236,700 with a category attached, or 90.3%. Abbott accounts for 62.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $105,496 and has fallen 91.7% since, to $8,783 in 2025. Among clinical cardiac electrophysiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $946.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$148K
- Sanofi-aventis U.S. LLC$24K
- Cvrx, Inc.$22K
- Boston Scientific$21K
- Altathera Pharmaceuticals LLC$8K
- Medtronic$7K
- plus $8K from 15 others
What the payments were for
- Consulting fees$213,73590%
- Speaking & faculty fees$10,1174%
- Grants$1470%
- Travel & lodging$5,2652%
- Food & beverage$7,4313%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 34 | $148,408 |
| Sanofi-aventis U.S. LLC | 12 | $24,110 |
| Cvrx, Inc. | 11 | $21,527 |
| Boston Scientific | 49 | $20,863 |
| Altathera Pharmaceuticals LLC | 3 | $7,508 |
| Medtronic(2 entities) | 23 | $6,665 |
| Preventice Services, LLC | 3 | $3,433 |
| Pfizer | 17 | $2,234 |
| Novartis | 30 | $587 |
| E.r. Squibb & Sons, L.L.C. | 23 | $333 |
| Johnson & Johnson | 25 | $309 |
| Biosense Webster, Inc. | 3 | $268 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $137 |
| Atricure, Inc. | 2 | $90 |
| Impulse Dynamics (USA) Inc. | 1 | $60 |
| Boehringer Ingelheim | 2 | $44 |
| Edwards Lifesciences | 1 | $38 |
| Baxter Healthcare | 2 | $34 |
| Innovation Technologies Inc | 1 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EP-4$68,719
- FlexAbility Ablation Catheter$44,731
- EP-4 Cardiac Stimulator$33,894
- MULTAQ$23,967
- Barostim Neo System$21,441
- GENERAL - THERAPIES$7,637
- Sotalol Hydrochloride$7,508
- ELIQUIS$1,732
- BG Mini Plus$1,508
- AVEIR$435
- BodyGuardian$253
- Farapulse$147
- Mitra Clip system$143
- AMPLATZER AMULET$141
- Quadra Assura CRT Defibrillator$139
- QUADRA ASSURA$131
- Carto 3$125
- CoreValve Evolut$122
- Micra$116
- LUX-Dx Insertable Cardiac Monitor$111
How this compares
$236,700 in reported general payments places this provider in the 95th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 785 | $791,218 |
| XareltoRivaroxaban | 268 | $303,105 |
| Dofetilide | 193 | $26,745 |
| MultaqDronedarone Hcl | 13 | $20,654 |
| Flecainide Acetate | 157 | $7,522 |
| Metoprolol Succinate | 238 | $2,987 |
| SotalolSotalol Hcl | 113 | $2,588 |
| Metoprolol Tartrate | 302 | $1,854 |
| Propafenone Hcl | 23 | $1,354 |
| Amiodarone Hcl | 77 | $1,315 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 45 | $1,294 |
| Verapamil ErVerapamil Hcl | 25 | $1,093 |
| Warfarin Sodium | 57 | $676 |
| Digoxin | 22 | $333 |
| Carvedilol | 25 | $169 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $2,234 | $791,218785 claims |
| Johnson & JohnsonXarelto | $309 | $303,105268 claims |
| Sanofi-aventis U.S. LLCMultaq | $24,110 | $20,65413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Atlanta
- David DelurgioAtlanta$695K
- Michael LloydAtlanta$221K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Bruce StamblerAtlanta$91K
- Stacy WestermanAtlanta$60K
- Ashish BhimaniAtlanta$51K
- Aaron RichardsonAtlanta$51K
- Devinder DhindsaAtlanta$47K
- Ahmadreza KarimianpourAtlanta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.